Welcome to LookChem.com Sign In|Join Free

CAS

  • or

96139-73-0

Post Buying Request

96139-73-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

96139-73-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 96139-73-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,1,3 and 9 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 96139-73:
(7*9)+(6*6)+(5*1)+(4*3)+(3*9)+(2*7)+(1*3)=160
160 % 10 = 0
So 96139-73-0 is a valid CAS Registry Number.

96139-73-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-nitrophenyl)-1,3-dihydroimidazol-2-one

1.2 Other means of identification

Product number -
Other names 4-(p-nitrophenyl)-4-imidazoline-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:96139-73-0 SDS

96139-73-0Downstream Products

96139-73-0Relevant articles and documents

Synthesis and anticonvulsant activity of some new 4-aryl-4-imidazoline-2-one derivatives

Calis,Dalkara,Ertan

, p. 592 - 594 (2007/10/02)

In this study, some new 4-aryl-4-imidazoline-2-one deriratives have been prepared by the reaction of potassium cyanate with some aminoethanone hydrochlorides. The structure of these compounds have been confirmed by UV, IR, 1H-NMR and elementary analysis. Their anticonvulsant activities were determined by maximal electroshock (MTS) and subcutaneous metrazol (scMet) tests according to the ADD (Antiepileptic Drug Development) programme Phase I. Neurotoxicity of the compounds was evaluated by rotarod test. While 2 of the compounds showed protection against ScMet induced seizures at 30 and 300 mg/kg dose levels, 3 of the compounds showed neurotoxicity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 96139-73-0